Article
05 Jul 2023
Commission Plans Liberalization Of New Genomic Techniques (NGTs) In The EU
AUTHORS CONTENT
Article
20 Jan 2023
EU MDR And IVDR Implementation: European Commission Publishes Full Proposal For Amending Transitional Regime
Article
23 Dec 2022
EU MDR And IVDR Implementation: Signs Of Relaxing Transitioning Regime And Bridging Measures
Article
07 Jun 2022
In Vitro Diagnostic Regulation Entered Into Force (Part 2 Of 3)
Article
01 Jun 2022
In Vitro Diagnostic Regulation Entered Into Force (Part 1 Of 3)
Article
13 Apr 2022
A Long Courtship For Unity – As Europe's Unitary Patent System Is Going Live Soon, Consultations About A Unitary Supplementary Protection Certificate Gain Momentum
Article
14 Dec 2021
Am Geld Wird Es Jedenfalls Nicht Scheitern
Article
10 Dec 2021
At Any Rate, It Won't Fail Because Of Money
Article
25 Jun 2021
Recent Developments Regarding Patent Injunctions In Germany
Article
11 Jun 2021
How Will Europe's New Device Regulations Affect Medical Software?
Article
31 May 2021
The European Commission's Take On Novel Genomic Techniques (NGTs) In Light Of CJEU's Ruling In Case C-528/16
Article
14 Apr 2021
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 6 Of 6)
Article
25 Mar 2021
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 5 Of 6)
Article
15 Mar 2021
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 4 Of 6)
Article
05 Mar 2021
Key EU Intellectual Property And Trade Secrets
Article
01 Mar 2021
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 3 Of 6)
Article
23 Feb 2021
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 2 Of 6)
Article
15 Feb 2021
Software As A Medical Device In Europe – New Regulatory Regime About To Enter Into Force – (Part 1 Of 6)
Article
21 Jan 2021
Top 10 Considerations When Drafting And Negotiating Sras, With U.S. And EU Perspectives
Article
23 Dec 2020
The European Commission's New Pharmaceutical Strategy For Europe
AWARDS
